Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance.

OBJECTIVES: To investigate whether selective reduction of postchallenge hyperglycaemia influences acute endothelial dysfunction, a very early manifestation of vascular disease, in patients with impaired glucose tolerance. METHODS: In a randomized, double-blind, placebo-controlled, cross-over study the acute effect of 200-mg acarbose was investigated in 28 subjects with diagnosed impaired glucose tolerance. Flow-mediated dilation (FMD) of the brachial artery was determined as a measure of endothelial function before and 2 and 3 h after ingestion of 100-g saccharose. Asymmetrical dimethylarginine (ADMA) was measured by high-performance liquid chromatography. RESULTS: A negative correlation was observed between the changes of glucose and FMD (r = 0.416, P = 0.0018) 2 h after ingestion of saccharose. At 3 h, neither blood glucose nor FMD were different from baseline. Changes of both blood glucose (P = 0.0007) and FMD (P = 0.046) were significantly lower after administration of acarbose. Subgroup analysis revealed that the effect of acarbose was restricted to those subjects with an increase of blood glucose above the median increase of glycaemia. No changes of plasma ADMA were observed. CONCLUSIONS: Our data clearly demonstrate that the postchallenge alteration of vascular function in patients with impaired glucose tolerance is caused by the acute elevation of glycaemia but not mediated by ADMA.

Real-time detection of vessel diameters with ultrasound.

Transcutaneous vessel imaging is a frequently used ultrasound imaging modality in medicine. The measurement of vessel diameters can be done with conventional B-mode imaging systems, which work at frame rates up to 100 Hz. Furthermore, there are special systems available, which can track vessel walls very precisely using the phase of signals that are sent at frame rates up to several thousand Hz. Though, such systems are usually not able to provide the examiner with 2D images of the object. With respect to brachial artery flow-mediated vasodilatation (FMD), which is frequently used as a measure of endothelial function, it is necessary to observe diameter changes of small arterial vessels noninvasively for several minutes at a high resolution. In the past, the diameter had to be measured manually in tedious postprocessing of ECG-gated image sequences. We developed a system composed of a Siemens Omnia ultrasound system with a VF13-5 transducer (9 MHz center frequency) and a personal computer, that is capable of calculating vessel diameter changes with an accuracy below the wavelength of the ultrasound system in real-time at a frame rate of 27 Hz. We implemented a two-dimensional active contour model using the Viter-bi-algorithm and a phase-sensitive vessel wall tracking algorithm, in order to guarantee both, geometric information and accuracy. Results from carotid and brachial arteries show that arterial pulsations below 0.1 mm can be visualized reliably over several minutes. With this system we want to find out, if FMD is suitable for an individual assessment of the risk for cardiovascular diseases.

[Measurement of flow mediated vasodilation (FMD) using kalman-filtering]. / Measurement of flow mediated vasodilation (FMD) using kalman-filtering.

Brachial artery flow-mediated vasodilation is increasingly used as a measure of endothelial function. High resolution ultrasound provides a noninvasive method to observe this flow-mediated vasodilation by monitoring the diameter of the artery over time. In the past, the diameter had to be measured in tedious postprocessing routines, usually by the examiner himself. We present a system, which is able to process ultrasound rf-data in realtime. On that system, we implemented a kalman filter, which makes the tracking of both vessel walls possible. The diameter can be calculated accurately, taking into account process noise as well as measurement noise.